Mode
Text Size
Log in / Sign up

Polio

Part of Picornaviridae Infections

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Polio

11 trials tracked for Polio: 9 in phase 3 or 4.

11Trials tracked
9Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 3 7 Phase 1 1 Other / NA 1
  1. Phase 4 Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan Completed
  2. Phase 4 Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ Completed
  3. Phase 3 Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants Completed
  4. Phase 3 Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV Completed
  5. Phase 3 Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants Completed
  6. Phase 3 Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age Completed
Show 5 more trials
  1. Phase 3 Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule Completed
  2. Phase 3 Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ Completed
  3. Phase 3 Safety and Immune Response of Different Pediatric Combination Vaccines. Completed
  4. Phase 1 Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults Completed
  5. N/A Retrospective Survey of Safety of Fourth Dose Pentacel® in Children Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Polio

What data does the report describe regarding Poliovirus in high-risk countries?

Reports describe poliovirus surveillance data from 40 high-risk countries, noting that Afghanistan, Pakistan, and Nigeria remain the only places with ongoing wild poliovirus transmission.

Full answer →
When will the new 6-in-1 vaccine that includes Polio be available?

A new 6-in-1 vaccine that includes protection against polio was licensed but was not available until at least 2021.

Full answer →
Which countries were identified as high risk for Polio virus transmission?

Polio transmission remains a risk in specific areas of Pakistan, conflict zones in Ethiopia, and regions in Africa and the Philippines affected by vaccine disruptions.

Full answer →